Back
RCM Technologies 10K Form
Buy
70
RCMT
RCM Technologies
Last Price:
$22.65
Seasonality Move:
5.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | RCMT/RCM Technologies Quarterly |
2023-11-09 | 10Q | RCMT/RCM Technologies Quarterly |
2023-08-10 | 10Q | RCMT/RCM Technologies Quarterly |
2023-05-10 | 10Q | RCMT/RCM Technologies Quarterly |
2022-11-10 | 10Q | RCMT/RCM Technologies Quarterly |
2022-08-11 | 10Q | RCMT/RCM Technologies Quarterly |
Receive RCMT News And Ratings
See the #1 stock for the next 7 days that we like better than RCMT
RCMT Financial Statistics
Sales & Book Value
Annual Sales: | $278.4M |
---|---|
Cash Flow: | $16.2M |
Price / Cash Flow: | 12.62 |
Annual Sales: | $4.61 |
Price / Book: | 4.85 |
Profitability
EPS (TTM): | 1.73000 |
---|---|
Net Income (TTM): | $13.6M |
Gross Margin: | $79.8M |
Return on Equity: | 43.47% |
Return on Assets: | 10.98% |
RCM Technologies Earnings Forecast
Key RCM Technologies Financial Ratios
-
The Gross Profit Margin over the past 38 years for RCMT is 28.66%.
-
The Selling, General & Administrative Expenses for RCMT have been equal to 20.40% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 16.62% of Operating Income.
-
The Net Earning history of RCMT is 4.79% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 20 years.
RCM Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Professional Services |
Sector: | Industrials |
Current Symbol: | RCMT |
CUSIP: | 749360 |
Website: | rcmt.com |
Debt
Debt-to-Equity Ratio: | 0.68 |
---|---|
Current Ratio: | 1.62 |
Quick Ratio: | 1.52 |
Price-to-Earnings
Trailing P/E Ratio: | 13.52 |
---|---|
Forward P/E Ratio: | 9.01 |
RCMT Technical Analysis vs Fundamental Analysis
Buy
70
RCM Technologies (RCMT)
is a Buy
Is RCM Technologies a Buy or a Sell?
-
RCM Technologies stock is rated a BuyThe current RCM Technologies [RCMT] share price is $22.86. The Score for RCMT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.